Dopamine and serotonin metabolism in the dorsal and ventral striatum of haloperidol-induced tardive dyskinesia model in rats

Journal of the Chemical Society of Pakistan

Volumn 30, Issue 3, 2008, Pages 410-416

  Khan, Asma ^a   Haleem, Muhammad Abdul ^b   Haleem, Darakhshan Jabeen ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b SIR SYED UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50649099478     PISSN: 02535106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. F. J. Ayd, Neurochem. Behavioral and Clinical Perspectives, 75 (1983).
2. K. L. Drew, W. T. O'Connor, J. Kehr and U. Ungerstedt, Eur. J. of Pharamacol., 187, 385 (1990).
3. H. L. Kalwans, J. Clin. Psychiatry, 46, 2 (1985).
4. H. L. Klawans and R. Rubovits, J. Neural. Transm., 33, 235 (1972).
5. D. V. Jeste and R. J. Wyatt, Skizphr. Bull., 5, 251 (1979).
6. G. Ellison and R. E. See, Psychopharmacol. (Berl)., 98, 564 (1989).
7. M. W. Jann, J.H. Froemming and R.L. Borison, Br. J. Pharmacol., 124, 148 (1990).
8. P. Jenner and C. D. Marsden. Adv. Neurol., 49, 417 (1988).
9. J. Tauscher, S. Kapur, N. P. Verhoeff, D. F. Hussey, Z. J. Daskakis, W. S. Tauscher, A. A. Wilson, S. Houle, S. Kasper and R. B. Zipursky, Arch. Gen. Psychiatry., 59, 514 (2002).
10. E. P. Prinssen, M. S. Kleven and W. Koek, Psychopharmacol., 144,20 (1999).
11. D. J. Haleem, E. Shireen and M. A. Haleem, Progress in Neuro-Psychopharmacol & Biol. Psychiat., 28, 1323 (2004).
12. D. J. Haleem, F. Batool, N. H. Khan, N. Kamil, O. Ali, Z. F. Saify and M. A. Haleem, Med. Sci. Monit., 8, 354 (2002).
13. A. Khan, F. Batool and D. J. Haleem, Pak. J. of Pharma. Sci., 14, 9 (2001).
14. D. J. Haleem and N. H. Khan, Progress in Neuro-Psychopharmacol & Biol. Psychiat., 11, 645 (2003).
15. E. Shireen, A. Khan, F. Batool and D. J. Haleem, J. of Basic & Appl Sci., 2, 45 (2006).
16. M. M. Marchus, C. G. Nomikoa and T. H. Sevensson, Eur. Neuropsychopharmacol., 10, 245 (2000).
17. A. Wirz-Justice, Biol. Psychiat., 19, 1274 (1984).
18. S. Ohdo, T Makinosumi, T. Ishizaki, E. Yukawa, S. Higuchi, S. Nakano and N. Ogawa, J Pharmacol. Exp. Ther., 283: 1383.
19. S. Koyanagi, S. Ohdo, E. Yukawa and S. Higuchi, J. Pharmacol Exp. Ther., 283, 259 (1997).
20. A. Campbell and R. J. Baldessarini, Life Sci., 29, 1341 (1981).
21. F. M. Radzialowski and W. F. Bousquet, J Pharmacol Exp. Ther., 163, 229 (1968).
22. A. Jori, E. DiSalle and V. Santini, Biochem. Pharmacol., 20, 2965 (1971).
23. D. J. Haleem, N. Samad and M. A. Haleem, Behav. Pharmacol., 18, 147 (2007).
24. J. Viyoch, S. Ohdo, E. Yukawa and S. Higuchi, J. Pharmacol. Exp.Ther., 289, 964 (2001).
25. P. S. Naidu and S. K. Kulkami, Eur. J. Pharmacol., 428, 81 (2001).
26. S. Chiu, C. S. Paulose and R. K. Mishra, Science., 214, 1261 (1981).
27. G. Marchese, M. A. Casu, F. Bartholini, S. Ruiu, P. Saba, G. L. Gessa and L. Panil, Eur. J. of Neurosci., 15, 1187 (2002).
28. S. K. Johnson, G. C. Wagner and H. Fischer, J. Neurochem., 56,228 (1992).
29. R. B. Rastogi, R. L. Singhal and Y. D. Lapierre, Life Sci., 29, 735 (1981).
30. L. Kozell, R. Sandyk, G. C. Wagner and H. Fischer, Life Sci., 41, 1739 (1987).
31. B. H. C Westcrnik, Neurochem., Int., 7, 221 (1985).
32. F. Karoum and M. F. Egan, Br. J. Pharmacol., 105, 703 (1992).
33. P. Teismann and B. Ferger, Prog. Neuropsy-cholpharmacol. and Biol. Psychiat., 24, 337 (2000).
34. E. Shireen, Qurat ul Ain, F. Batool, Z. S. Saify and D. J. Haleem, Pak. J. of Pharma. Sci., 15, 71 (2002).
35. M. He, E. Sibille, D. Benjamin, M. Toth and T. Scippenberg, Brain Res., 11, 902 (2001).
36. D. J. Haleem and T. Perveen, Neuroreport, 5, 1785 (1994).